Gumampong, Baby Boy .

HRN: 22-39-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/15/2023
01/22/2023
IV
170 Mg
Q12
Neonatal Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: